Explore our newest products

We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.

Find out more information on our newest products:

Sustainably sourced Squalene

Introducing our sustainably sourced Squalene, produced using cutting-edge technology that centres on synthetic biology, our pharmaceutical-grade squalene has superior purity and carries the same squalene benefits as shark-derived squalene.

Learn more

Sustainable saponins (2024)

As we look to become more nature positive, we’re proud to be able to offer our next-generation QS 21 and support global sustainability efforts. Our next-generation QS 21 is based on plant tissue culture, which makes the process more efficient and sustainably sourced.

Learn more

Introducing Virodex™

We’re introducing our new range of detergents specifically designed to support the key steps in your biomanufacturing processes. The Virodex™ range for viral inactivation and cell lysis is REACH-compliant, compendial, sustainable, and has been optimised for use in biomanufacturing of recombinant proteins, blood fractionation products, viral vectors, and more.

View

Introducing NatraPhos™, our highly purified, natural phospholipids:

4 items available

NatraPhos Soya PC100-C Pharma

NatraPhos™ Soya PC100-C is a highly purified soybean lecithin containing predominantly phosphatidylcholine.

Add product to favourites View product
NatraPhos™ PL95E Pharma

NatraPhos™ PL95E is a highly purified egg yolk lecithin containing predominantly phosphatidylcholine and a smaller amount of phosphatidylethanolamine.

Add product to favourites View product
NatraPhos™ Soya PC80-C Pharma

NatraPhos™ Soya PC80-C is a highly purified soybean lecithin containing predominantly phosphatidylcholine.

Add product to favourites View product
NatraPhos™ PL95EN Pharma

NatraPhos™ PL95EN is a highly purified egg yolk lecithin containing predominantly phosphatidylcholine and a smaller amount of phosphatidylethanolamine.

Add product to favourites View product

How we empower biologics delivery

Enabling breakthrough innovation

Dedicated to developing the next generation of excipients and delivery systems to empower biopharma

Access to specialist formulation support

Enabling over 250 on-going clinical projects targeting a range of therapeutic areas across biologics and small molecules

Focused scientific expertise

Leading the way with specialist knowledge and synthesis expertise in excipients, adjuvants and lipids

Explore recent blogs:

Lipid Leaders: Söhnke Voss

In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...

Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards

Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...

Partnership agreement between Croda and AAHI to drive innovation in vaccine development

19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...

Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.

Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.

Please provide an enquiry type

Country